United States
Search    
Include All CSL Behring Country Sites

Humate-P®

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized

Humate-P® is indicated (1) in adult patients for treatment and prevention of bleeding in hemophilia A (classical hemophilia) and (2) in adult and pediatric patients for treatment of spontaneous and trauma-induced bleeding episodes in severe von Willebrand disease, and in mild and moderate von Willebrand disease where use of desmopressin is known or suspected to be inadequate.

Humate-P®
  • 2.4 ristocetin cofactor (RCo) international units per 1 antihemophilic factor international unit
  • Presence of high molecular weight multimers of VWF
  • Contains no preservatives

null

NDC Number
Product Description

0053-7615-05

AHF/von Willebrand 600 RCo per vial

0053-7615-10

AHF/von Willebrand 1200 RCo per vial

0053-7615-20

AHF/von Willebrand 2400 RCo per vial


null Use the unique Humate-P® Dosage Calculator, which makes individual dosing fast, easy and convenient.

Important Safety Information

Humate-P® is contraindicated in individuals with a history of anaphylactic or severe systemic response to antihemophilic factor or von Willebrand factor preparations, or to any of its components.

Thromboembolic events have been reported in VWD patients receiving coagulation factor replacement, especially in the setting of known risk factors for thrombosis. Caution should be exercised and antithrombotic measures considered.

Humate-P® is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

The most common adverse reactions reported in patients receiving Humate-P® are allergic-anaphylactic reactions, including urticaria, chest tightness, rash, pruritus, edema, shock, chills and fever, and hypervolemia. For patients undergoing surgery, the most common adverse reactions are postoperative wound or injection-site bleeding.

Please see full prescribing information.

View universal billing codes for Humate®

CUSTOMER SUPPORT 1-800-683-1288 or Customer Services

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Frequently Asked Questions for Humate-P®

To learn more about Humate-P® for the treatment of von Willebrand Disease (VWD), please visit www.Humate-P.com

Last Updated: 11 February 2010